nifedipine has been researched along with c-peptide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attali, JR; Perret, G; Uzzan, B; Valensi, P | 1 |
| Adib, S; Benco, R; Ghilardi, G; Gianola, D; Pagani, G; Pedroncelli, A; Stroppa, S; Tentorio, A | 1 |
| Kerp, L; Khalaf, N; Ortgiese, R; Petersen, KG; Schliebs, B; Schuler, G | 1 |
| Antonacci, A; Pirrelli, A; Vulpis, V | 1 |
| Kondo, M; Miyamura, K; Moriyama, Y; Nanjo, K; Nishi, M; Sanke, T | 1 |
| Baty, J; Dow, RJ; Isles, TE | 1 |
| Greenwood, RH | 1 |
| Czyzyk, A; Jasik, M; Kasperska-Dworak, A | 1 |
| Adner, N; Gutniak, M; Holst, JJ; Svartberg, J | 1 |
| Hattori, Y; Irie, M; Takeda, S; Ueshiba, H | 1 |
| Kim, MS; Kong, YH; Lee, DY | 1 |
| Basak, D; Chatterjee, S; Flanagan, SE; Hussain, K; Khawash, P | 1 |
| Gao, G; Guo, D; Li, YX; Liu, H; Liu, Y; Nasir, A; Ruzi, A; Wu, F; Xu, G; Yang, F | 1 |
5 trial(s) available for nifedipine and c-peptide
| Article | Year |
|---|---|
Effects of nifedipine and nitrendipine on insulin secretion in obese patients.
Topics: Adult; Analysis of Variance; Blood Glucose; C-Peptide; Double-Blind Method; Female; Humans; Hypertension; Insulin; Insulin Secretion; Male; Middle Aged; Nifedipine; Nitrendipine; Obesity; Time Factors | 1991 |
[Glucose tolerance and electrolyte metabolism in nifedipine and nifedipine dihydroergotoxin treated healthy subjects].
Topics: Adult; C-Peptide; Dihydroergotoxine; Electrolytes; Glucose; Glucose Tolerance Test; Heart Rate; Humans; Insulin; Male; Nifedipine; Norepinephrine; Renin | 1989 |
The effect of nicardipine on glucose and drug-stimulated insulin secretion in normal volunteers.
Topics: Adult; Blood Glucose; C-Peptide; Calcium Channel Blockers; Glucose; Humans; Insulin; Insulin Secretion; Male; Nicardipine; Nifedipine; Tolbutamide | 1985 |
The ethanol augmentation of glucose-induced insulin secretion is abolished by calcium antagonism with nifedipine: no evidence for a role of glucagon-like peptide-1 (GLP-1).
Topics: Adult; C-Peptide; Calcium Channel Blockers; Ethanol; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Nifedipine; Peptide Fragments; Protein Precursors | 1998 |
Cilnidipine, the N- and L-type calcium channel antagonist, reduced on 24-h urinary catecholamines and C-peptide in hypertensive non-insulin-dependent diabetes mellitus.
Topics: Aged; C-Peptide; Calcium Channel Blockers; Catecholamines; Chromatography, High Pressure Liquid; Cross-Over Studies; Diabetes Mellitus, Type 2; Dihydropyridines; Dopamine; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Norepinephrine | 1999 |
8 other study(ies) available for nifedipine and c-peptide
| Article | Year |
|---|---|
Insulin secretion and glucose tolerance in non-insulin dependent diabetic patients after chronic nifedipine treatment.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Secretion; Middle Aged; Nifedipine; Time Factors | 1989 |
[Extracardiovascular effects of nifedipine in the treatment of hypertensive patients: glucose tolerance and behavior of immunoreactive insulin].
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Male; Middle Aged; Nifedipine | 1988 |
Effect of calcium antagonists on reactive hypoglycemia associated with hyperinsulinemia.
Topics: Adult; Aged; C-Peptide; Calcium Channel Blockers; Diltiazem; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemia; Male; Middle Aged; Nicardipine; Nifedipine | 1986 |
Hyperglycaemic effect of nifedipine.
Topics: Blood Glucose; C-Peptide; Humans; Male; Nifedipine; Pyridines | 1982 |
Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 (non-insulin-dependent) diabetes and in hypertensive non-diabetics.
Topics: Adult; Antihypertensive Agents; Blood Glucose; C-Peptide; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Nifedipine; Prazosin | 1996 |
A Case of Subclinical Hypothyroidism with Lingual and Right Pretracheal Ectopic Thyroid.
Topics: Blood Glucose; C-Peptide; Calcium Channel Blockers; Choristoma; Codon, Nonsense; Congenital Hyperinsulinism; Diazoxide; Diuretics; Drug Resistance; Female; Humans; Infant, Newborn; Insulin; Nifedipine; Octreotide; Pancreatectomy; Sulfonylurea Receptors; Thyroid Gland; Tongue Diseases | 2015 |
Nifedipine in Congenital Hyperinsulinism - A Case Report.
Topics: Blood Glucose; C-Peptide; Calcium Channel Blockers; Codon, Nonsense; Congenital Hyperinsulinism; Diazoxide; Diuretics; Drug Resistance; Female; Humans; Infant, Newborn; Insulin; Nifedipine; Octreotide; Pancreatectomy; Sulfonylurea Receptors | 2015 |
Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9.
Topics: C-Peptide; Cell Differentiation; Congenital Hyperinsulinism; CRISPR-Cas Systems; Gastrointestinal Agents; Gene Editing; Human Embryonic Stem Cells; Humans; Insulin; Insulin Antagonists; Insulin-Secreting Cells; Models, Biological; Nicorandil; Nifedipine; Octreotide; Phenotype; Potassium Chloride; Sulfonylurea Receptors; Vasodilator Agents | 2017 |